NEW YORK (Reuters Health) – For patients presenting to the emergency department (ED) with migraine, IV prochlorperazine with diphenhydramine is more effective than subcutaneous sumatriptan, a small prospective…
NEW YORK (Reuters Health) – All cesarean sections put women at increased risk of adverse events, including death, according to the World Health Organization’s Global Survey on Maternal…
NEW YORK (Reuters Health) – Just like cocaine and other drugs that increase brain dopamine levels, the dopamine agonists used to treat Parkinson disease can also produce a…
NEW YORK (Reuters Health) – Patients with non-ST-segment elevation acute coronary syndrome and elevated troponin T get no long term benefits from early invasive treatment as opposed to…
NEW YORK (Reuters Health) – Ventilator-associated pneumonia is less likely to be fatal when patients are intubated with a silver-coated endotracheal tube, according to a post hoc analysis…
NEW YORK (Reuters Health) – Magnetic guidewire navigation is feasible in primary percutaneous coronary intervention (PCI), according to results of a noninferiority trial performed in the Netherlands. Moreover,…
NEW YORK (Reuters Health) – When oxytocin is unavailable, misoprostol appears to be a viable alternative for first-line treatment of primary postpartum hemorrhage, according to two articles published…
NEW YORK (Reuters Health) – Women with gestational diabetes are more likely to maintain target glucose levels with glyburide than with metformin, a randomized trial has shown. The…
NEW YORK (Reuters Health) – Only about half of small abdominal aortic aneurysms (AAA) will increase in size, and those that grow less than 1.5 mm per year…
NEW YORK (Reuters Health) – Adenosine is less able to convert paroxysmal supraventricular tachycardia (SVT) to sinus rhythm when it’s given within 4 hours of caffeine ingestion, Australian…